期刊文献+

玄参提取物抗炎与抗动脉硬化作用的探索 被引量:51

Research on the Anti-inflammation and Anti-atherosclerosis of Extracts from Radix Scrophulariae
暂未订购
导出
摘要 目的观察玄参提取物对大鼠动脉硬化及其炎症相关细胞因子的影响。方法将大鼠随机分为正常组、模型组、玄参提取物低剂量组、玄参提取物高剂量组和布洛芬组。模型组及各给药组采用一次性腹腔注射维生素D360万单位/kg,同时每天灌服10 ml/kg脂肪乳的方法制备大鼠动脉硬化模型。玄参低剂量组和高剂量组分别每天灌服玄参提取物20.5mg.kg-1.d-1和41.0 mg.kg-1.d-1,布洛芬组每天灌服布洛芬混悬液144 mg.kg-1.d-1,正常组和模型组每天灌服等量蒸馏水。给药70 d后处死大鼠,对血脂、TNF-α,IL-1β,IL-6,IL-10及NF-кB进行测定,并观察动脉的病变情况。结果玄参提取物可明显降低模型大鼠胆固醇和低密度脂蛋白的水平,提高高密度脂蛋白与低密度脂蛋白的比值,降低炎症因子TNF-α,IL-1β,IL-6的浓度,提高抗炎因子IL-10的浓度,抑制动脉NF-кB过量表达,抑制模型大鼠动脉壁中膜的增厚。结论玄参提取物可通过抗炎和降血脂而发挥一定的抗动脉硬化的作用。 Objective To study the effect of extract from Radix Scrophulariae(RS) against atherosclerosis and the relative mechanisms in rats.Methods Rats were randomly divided into 5 groups.They were the conrtol,model,low and high dose of RS extract and ibuprofen groups.The model rats were intraperitoneally injected with 600 000 IU·kg^-1 vitamine D3 and intragastrically administrated high-fat emulsion 10 mg·kg^-1·d^-1 for 70 days.At the same time,the model rats treated with drugs were orally given 20.5mg·kg^-1·d^-1,41.0 mg·kg^-1·d^-1 RS extract and 144.0mg·kg^-1·d^-1 ibuprofen suspension respectively.After 70days,the rats were killed,and the serum levels of TC,TG,LDL,HDL/LDL,TNF-α,IL-1β,IL-6,IL-10,the expression of NF-кB in rat aorta and the pathological change of aorta were measured.Results RS extract could lower the serum levels of TC,LDL-C,TNF-α,IL-1β and IL-6,increase the level of IL-10 and the ratio of HDL/LDL,inhibit the expression of NF-кB and reduce the thickness of the artery wall.Conclusion RS extract has anti-atherescle ratic effect.The mechanism may be related with inhibiting inflammation and lowering serum lipid.
机构地区 上海中医药大学
出处 《时珍国医国药》 CAS CSCD 北大核心 2010年第3期532-534,共3页 Lishizhen Medicine and Materia Medica Research
基金 上海市教育委员会科研项目(No.06CZ035) 科技部"重大新药创制"科技重大专项(No.2009ZX09103-398)
关键词 玄参提取物 动脉硬化 抗炎 血脂 Radix Scrophulariae extracts Atherosclerosis Anti-inflammation Serum lipid
  • 相关文献

参考文献17

  • 1郭立新.血脂异常与动脉粥样硬化的研究进展[J].世界医学杂志,2002,6(11):42-44. 被引量:12
  • 2国家药典委员会.中国药典:Ⅰ部[S].北京:化学工业出版社,2005.附录Ⅵ,ⅦA,ⅦG.
  • 3杨鹏远,芮耀诚,焦亚斌.动脉粥样硬化大鼠实验模型的建立[J].第二军医大学学报,2003,24(7):802-804. 被引量:153
  • 4陈花,王建昌,孟如松,唐雅望,梁东明,张婧.血管黏附蛋白-1、核因子-κB在动脉粥样硬化斑块中的表达及其意义[J].中国老年学杂志,2007,27(14):1342-1344. 被引量:8
  • 5Ross R. Atherosclerosis an inflammatory disease [ J]. N Engl J Med, 1999,340(2) :115.
  • 6Li, Messas E, Batista EL Jr, et al. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a hetemzygous apolipoprotein E- deficient murine model[ J ]. Circulation,2002,105 (7) : 861.
  • 7O'Connor S, Taylor C, Campbel LA, et al. Potential infectious etiologies of atherosclerosis: a multi - factorial perspective [ J ]. Emerg Infect Dis,2001,7 (5) :780.
  • 8Boesten LS, Zadelaar AS,Van Nieuwkoop A, et al. Tumor necrosis factor - alpha promotes atheroselemtic lesion progression in APOE * 3 - Leiden transgenic mice[J]. Cardiovasc Res,2005,66 (1) :179.
  • 9McGlinchey PG, Spence MS, Patterson CC, et al. Cytokine gene polymerph - isms in ischaemic heart disease: investigation using family - basedtests of association[J]. J Mol Med,200d-,82( 11 ):756.
  • 10Goldhammer E,Tanehilevitch A, Maor I, et al. Exercise training modul - ates cytokines activity in coronary heart disease patients [ J ]. Int J Cardiol,2005,100( 1 ) :93.

二级参考文献28

  • 1芮耀诚.抗动脉粥样硬化药物研究进展[J].国外医学(药学分册),1995,22(5):257-261. 被引量:15
  • 2吴开云,高摄渊,袁融,庄文华.维生素D诱发大鼠动脉粥样硬化的实验研究[J].解剖学报,1996,27(2):133-135. 被引量:31
  • 3Martin MJ, Hulley SB, Browner WS et al. Serum cholesterol,blood pressure,and morality:implications from a cohort of 361,662men Lancet 1986; ii: 933-939.
  • 4Scandinavian Simvastatin Survival Study Group,Randomised trial of choksterol lowering in 4444 patients with coronary heart disease:the Scandinavian Simvastatin Survival Study 4S.Laocet 1994;344:1383-1389.
  • 5Shepherd J,Cobbes SM,Ford I,et al Prevention of coronary beart disease with pravastation in men with hypercbolesterolemia,N Engl J Med 1995;3331301-1307.
  • 6Bhatnagar B,Lipid-lowering drugs in the management of hyperlipidaemia Phamacol Ther 1998.79:205-230.
  • 7National Cholesterol Education Program,Second Report of Expert Panel on Detertion,Evalution,and Treatment of High Blood Cholesterol in Adults(Adult Treatment Panel Ⅱ).Circulation 1994;89:1333-1445.
  • 8Ansell BJ,Watson KE,Fogelman AM,et al An evidence-based assessment of the NCEP Adult Treatment Panel Ⅱ guidelines, J Am Med Assoc 1999;282:2051-2057.
  • 9Leiter LA,Low-density lipoprotein cholesterol:is lower better?Can J Cardiol 2000;16:20A-22A.
  • 10Blumenthal RS,Statins:Effective antiatherosclerotic therapy,Am Heart J 2000;139:577-583.

共引文献512

同被引文献726

引证文献51

二级引证文献677

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部